Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05057676 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Autoimmune Intervention Mastery Course Study

Study acronym: AIM
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 5 of 21 entries
    • Publications: details revised at 10 of 10 entries
    • Eligibility criteria expanded, about 2 words
  2. Enrollment closed, study ongoing
    • Site details revised
    v10
  3. Secondary endpoints: 20 to 21v9
  4. Enrollment target: 80 to 400
    • Primary and study completion dates: Dec 1, 2026 to Dec 1, 2027
    • Site contact updated
    v8
  5. Primary endpoints: 6 to 8
    • Secondary endpoints: 18 to 20
    • Study description expanded, about 33 words
    v7
Show 5 earlier versionsHide 5 earlier versions
  1. Primary endpoints: 4 to 6v6
  2. Trial status: Active, Not Recruiting to Recruitingv5 Show 5 more changesShow less
    • Primary and study completion dates: Dec 1, 2023 to Dec 1, 2026
    • Eligibility criteria expanded, about 50 words
    • Secondary endpoints: 10 to 18
    • Study description expanded, about 6 words
    • Site details revised
  3. Trial status: Recruiting to Active, Not Recruiting
    • Site details revised
    v4
  4. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Nov 1, 2021 to Dec 1, 2021
    v3
  5. Interventions: Delayed Autoimmune Intervention Mastery Course (Behavioral), Delayed Question and Answer sessions (Behavioral), Immediate Autoimmune… to Delayed AIM Question and Answer sessions (Behavioral), Delayed Autoimmune Intervention Mastery Course (delayed AIM course) (Behavioral)…
    • Study description shortened, about 8 words
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this project is to critically evaluate the effectiveness of using an online program to improve diet and self-care in patients with multiple sclerosis (MS), clinically isolated syndrome (CIS), fibromyalgia, post acute sequela of covid, and cancer in remission with persisting fatigue.
Trial Details
NCT Number NCT05057676
Lead Sponsor Terry L. Wahls
Conditions
(from sponsor)		 Multiple Sclerosis, Clinically Isolated Syndrome, Fibromyalgia, Post Acute Sequelae of COVID-19, Cancer in Remission With Persisting Fatigue
Related terms Fibromyalgia, Multiple Sclerosis, Post-Acute COVID-19 Syndrome
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov